Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Organon Abandons Gepirone Following Second “Not Approvable” Letter
Jun 25 2004
•
By
Alla Rutstein Bobbitt
More from Archive
More from Pink Sheet